In an try to boost connections between sufferers, radiologists, and different subspecialty suppliers, Nanox has added three synthetic intelligence (AI) instruments to its Second Opinions teleradiology platform for chest and stomach computed tomography (CT) scans.
The three AI instruments, HealthCCSng, HealthOST and HealthFLD, have beforehand garnered 510(ok) clearance from the Meals and Drug Administration (FDA).
HealthOST, which may determine low bone mineral density (BMD) and help within the detection of compression fractures, is certainly one of three FDA-cleared AI instruments which have been added to Nanox’s Second Opinions teleradiology platform for chest and stomach CT scans. (Picture courtesy of Nanox.)
Nanox stated HealthCCSng allows detection of coronary artery calcium, which may be an early indicator of coronary artery illness (CAD). Different built-in AI-powered instruments embody HealthFLD, which can facilitate detection of fatty liver illness via liver density measurements, and HealthOST, which may determine low bone mineral density (BMD) and help within the detection of compression fractures, in keeping with Nanox.
“The mixing of Nanox.AI’s options into the Second Opinions service will assist empower radiologists and different healthcare suppliers by offering them with superior AI instruments that goal to enhance affected person outcomes,” famous Erez Meltzer, the chief government officer of Nanox. “We’ll proceed exploring alternatives to leverage our AI know-how to advertise accessible early analysis and preventative administration.”
